Alvotech () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1291009,
    "name": "Alvotech",
    "stock_name": "Alvotech",
    "full_name": "Alvotech",
    "name_url": "stocks-analysis/alvotech",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "5.07",
    "chg": 0.47,
    "chgp": "10.22%",
    "dir": 1,
    "prev_price": "4.60",
    "mcapval": "2,462.73",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "LU2458332611",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.22 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alvotech-1291009-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alvotech Stock Soars 12.85%, Hits Intraday High of $5.71",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alvotech-stock-soars-1285-hits-intraday-high-of-571-3686601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Alvotech_priceRelatedfactors_3686601.png",
        "date": "2025-11-10 17:57:25",
        "description": "Alvotech, a small-cap pharmaceutical company, saw a significant intraday gain today, contrasting with the modest rise of the S&P 500. However, the company faces long-term challenges, including a substantial decline over the past year and weak financial metrics, indicating a complex market position."
      },
      {
        "title": "Alvotech Shares Plunge to New 52-Week Low of $4.70",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alvotech-shares-plunge-to-new-52-week-low-of-470-3674079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Alvotech_priceRelatedfactors_3674079.png",
        "date": "2025-11-05 16:57:28",
        "description": "Alvotech, a small-cap pharmaceutical company, has reached a new 52-week low, reflecting a substantial decline in stock performance over the past year. Despite impressive growth in net sales and operating profit, the company faces financial challenges, including a negative book value and a high debt-to-equity ratio."
      },
      {
        "title": "Alvotech Stock Hits Day Low of $4.81 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alvotech-stock-hits-day-low-of-481-amid-price-pressure-3671599",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Alvotech_priceRelatedfactors_3671599.png",
        "date": "2025-11-04 18:36:53",
        "description": "Alvotech, a small-cap pharmaceutical company, faced significant stock volatility on November 3, 2025, with a notable decline in its share price. Over the past year, the company has struggled with a negative book value and weak debt servicing capabilities, despite a substantial increase in profits."
      },
      {
        "title": "Alvotech Shares Plunge to New 52-Week Low of $4.81",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alvotech-shares-plunge-to-new-52-week-low-of-481-3671552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Alvotech_priceRelatedfactors_3671552.png",
        "date": "2025-11-04 18:08:16",
        "description": "Alvotech has reached a new 52-week low, reflecting significant challenges in its financial performance. Despite impressive growth rates in net sales and operating profit over the past five years, the company has struggled with declining stock value and negative financial metrics, including a concerning return on equity."
      },
      {
        "title": "Alvotech Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alvotechs-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-mixed-indicators-3640523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/Alvotech_technicaldot_3640523.png",
        "date": "2025-10-20 15:34:04",
        "description": "Alvotech, a small-cap pharmaceutical company, has experienced a challenging year with a significant decline in stock performance. Despite recent weekly and monthly gains, the overall year-to-date return remains negative. Technical indicators present a mixed outlook, reflecting ongoing volatility in the market."
      },
      {
        "title": "Alvotech Hits Day High with 8.61% Surge Amid Intraday Trading Boost",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alvotech-hits-day-high-with-861-surge-amid-intraday-trading-boost-3565192",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/Alvotech_priceRelatedfactors_3565192.png",
        "date": "2025-09-24 13:12:20",
        "description": "Alvotech, a small-cap pharmaceutical company, experienced notable stock activity today, reaching an intraday high. However, it has struggled recently, with significant declines over the past week and year-to-date. Financial metrics reveal a negative book value and weak fundamental strength, highlighting ongoing challenges in the market."
      },
      {
        "title": "Is Alvotech technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alvotech-technically-bullish-or-bearish-3548677",
        "imagepath": "",
        "date": "2025-09-20 20:23:34",
        "description": "As of 31 July 2025, the technical trend for Alvotech has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators: both the weekly and monthly MACD are bearish, Bollinger Bands are bearish across both time frames, and daily moving averages also signal bearishness. The KST is bearish on both weekly and monthly charts, while Dow Theory and OBV indicate a mildly bearish trend. \n\nIn terms of performance, Alvotech has underperformed the S&P 500 significantly, with a year-to-date return of -40.89% compared to the S&P 500's 12.22%, and a one-year return of -29.36% against the S&P 500's 17.14%...."
      }
    ],
    "total": 11,
    "sid": "1291009",
    "stock_news_url": "https://www.marketsmojo.com/news/alvotech-1291009"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Alvotech Stock Soars 12.85%, Hits Intraday High of $5.71

2025-11-10 17:57:25

Alvotech, a small-cap pharmaceutical company, saw a significant intraday gain today, contrasting with the modest rise of the S&P 500. However, the company faces long-term challenges, including a substantial decline over the past year and weak financial metrics, indicating a complex market position.

Alvotech Shares Plunge to New 52-Week Low of $4.70

2025-11-05 16:57:28

Alvotech, a small-cap pharmaceutical company, has reached a new 52-week low, reflecting a substantial decline in stock performance over the past year. Despite impressive growth in net sales and operating profit, the company faces financial challenges, including a negative book value and a high debt-to-equity ratio.

Alvotech Stock Hits Day Low of $4.81 Amid Price Pressure

2025-11-04 18:36:53

Alvotech, a small-cap pharmaceutical company, faced significant stock volatility on November 3, 2025, with a notable decline in its share price. Over the past year, the company has struggled with a negative book value and weak debt servicing capabilities, despite a substantial increase in profits.

Alvotech Shares Plunge to New 52-Week Low of $4.81

2025-11-04 18:08:16

Alvotech has reached a new 52-week low, reflecting significant challenges in its financial performance. Despite impressive growth rates in net sales and operating profit over the past five years, the company has struggled with declining stock value and negative financial metrics, including a concerning return on equity.

Alvotech Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators

2025-10-20 15:34:04

Alvotech, a small-cap pharmaceutical company, has experienced a challenging year with a significant decline in stock performance. Despite recent weekly and monthly gains, the overall year-to-date return remains negative. Technical indicators present a mixed outlook, reflecting ongoing volatility in the market.

Alvotech Hits Day High with 8.61% Surge Amid Intraday Trading Boost

2025-09-24 13:12:20

Alvotech, a small-cap pharmaceutical company, experienced notable stock activity today, reaching an intraday high. However, it has struggled recently, with significant declines over the past week and year-to-date. Financial metrics reveal a negative book value and weak fundamental strength, highlighting ongoing challenges in the market.

Is Alvotech technically bullish or bearish?

2025-09-20 20:23:34

As of 31 July 2025, the technical trend for Alvotech has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators: both the weekly and monthly MACD are bearish, Bollinger Bands are bearish across both time frames, and daily moving averages also signal bearishness. The KST is bearish on both weekly and monthly charts, while Dow Theory and OBV indicate a mildly bearish trend. In terms of performance, Alvotech has underperformed the S&P 500 significantly, with a year-to-date return of -40.89% compared to the S&P 500's 12.22%, and a one-year return of -29.36% against the S&P 500's 17.14%....

View All News